By reducing CHL1 protein levels with shRNA, a dramatic increase in non-neoplastic HBL-100 cell proliferation and migration was found (around 2-fold), but not in cell invasion, suggesting that CHL1 might act as a tumour suppressor gene in the early stages of BC development. The gene discussed is CHL1; the disease is breast cancer.